Global /China /Healthcare /Drug Manufacturers - General /600351

Yabao Pharmaceutical Group Co., Ltd.

600351

• SSE: 600351 • Delayed

7.08CNY 2.3%

1.05 USD

As of 14 June 2026, Yabao Pharmaceutical Group Co., Ltd. has a market cap of $723.05M USD, ranking #12732 globally and #3811 in China. It ranks #1162 in the Healthcare sector, and #432 in the Drug Manufacturers - General industry.

Global Rank

12732

Country Rank

3811

Sector Rank

1162

Industry Rank

432

Key Stats

Market Cap

$723.05MUSD

4.9B CNY

Enterprise Value

$592.67MUSD

4.01B CNY

Revenue (TTM)

$324.31MUSD

2.2B CNY

EBITDA (TTM)

$71.8MUSD

485.88M CNY

Net Income (TTM)

$47.14MUSD

319.41M CNY

EBITDA Margin

22%

Profit Margin

15%

PE Ratio

15.4

PS Ratio

2.2

PB Ratio

1.8

EV/EBITDA

8.2

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Wei Ren open_in_new

Employees

3,611

Founded

1978

Website

yabao.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.3%	6.3%	6.3%	2.1%	3.6%	6.6%	15%	-3.9%	23%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	600351 亚宝药业集团股份有限公司 Class A ISIN: CNE000001CM5 Shares Out.: Shares Outstanding: 692.0M¹ Shares Float: 683.013M² TV: TradingView: SSE: 600351 SA: Stock Analysis: SHA: 600351 YF: Yahoo Finance: 600351.SS GF: Google Finance: SHA: 600351 BA: Barron's: 600351 MS: Morningstar: XSHG: 600351	7.08 CNY	TV: TradingView: SSE: 600351 SA: Stock Analysis: SHA: 600351 YF: Yahoo Finance: 600351.SS GF: Google Finance: SHA: 600351 BA: Barron's: 600351 MS: Morningstar: XSHG: 600351

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Yabao Pharmaceutical Group Co., Ltd.

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Beijing, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 7K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 7K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 4K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 105K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 76K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 50K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 44K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 40K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 38K%	20.5	Switzerland

chevron_leftBack